myMatrixx helped workers' compensation plans reduce overall drug spending by 3.8%, including the largest decrease yet in spending on opioids.
Our latest research report reveals increased use of single-tablet HIV regimens can yield lower costs and better outcomes; underscores need to expand affordable access to PrEP.
An Express Scripts report focuses on U.S. opioid trends for treatment of short-term and longer-term pain.
An Express Scripts Report on U.S. Medication Trends for Attention Deficit Hyperactivity Disorder